Study Design: Systematic literature review. Objective: To assess the efficacy of deep friction massage (DFM) in the treatment of tendinopathy. Context: Anecdotal evidence supports the efficacy of DFM for the treatment of tendinopathy. An advanced understanding of the etiopathogenesis of tendinopathy and the resultant paradigm shift away from an active inflammatory model has taken place since the popularization of the DFM technique by Cyriax for the treatment of "tendinitis." However, increasing mechanical load to the tendinopathic tissue, as well as reducing molecular cross-linking during the healing process via transverse massage, offers a plausible explanation for observed responses in light of the contemporary understanding of tendinopathy. Evidence Acquisition: The authors surveyed research articles in all languages by searching PubMed, Scopus, Pedro, CINAHL, PsycINFO, and the Cochrane Library using the terms deep friction massage, deep tissue massage, deep transverse massage, Cyriax, soft tissue mobilization, soft tissue mobilisation, cross friction massage, and transverse friction massage. They included 4 randomized comparison trials, 3 at the extensor carpi radialis brevis (ECRB) and 1 supraspinatus outlet tendinopathy; 2 nonrandomized comparison trials, both receiving DFM at the ECRB; and 3 prospective noncomparison trials-supraspinatus, ECRB, and Achilles tendons. Articles meeting inclusion criteria were assessed based on PEDro and Centre for Evidence-Based Medicine rating scales. Results: Nine studies met the inclusion criteria. Evidence Synthesis: The heterogeneity of dependent measures did not allow for meta-analysis. Conclusion: The varied locations, study designs, etiopathogenesis, and outcome tools used to examine the efficacy of DFM make a unified conclusion tenuous. There is some evidence of benefit at the elbow in combination with a Mills manipulation, as well as for supraspinatus tendinopathy in the presence of outlet impingement and along with joint mobilization. The examination of DFM as a single modality of treatment in comparison with other methods and control has not been undertaken, so its isolated efficacy has not been established. Excellent anecdotal evidence remains along with a rationale for its use that fits the current understanding of tendinopathy.
Tendinopathy is commonly treated in physical therapy clinics and athletic training rooms. Commonly affected areas include the Achilles, 1 posterior tibialis, [3] [4] [5] [6] patellar, 7, 8 lateral elbow, 10 and rotator-cuff tendons. 11, 12 The Achilles tendon is the most commonly affected lower extremity structure, with a cumulative lifetime incidence of 5.9% 1 in an inactive population and 50% in elite endurance athletes. 1 The patellar tendon, involved in "jumper's knee," is affected 12% of elite athletes among an assortment of sports, and injury incidence may be as high as 40% in jumping sports such as basketball and volleyball. 7, 8 Tendinopathy in the lateral extensor mass of the forearm occurs in approximately 1% to 3% of the general population 9 and 9% to 35% of tennis players. 10 A host of conservative treatments have been proposed for tendinopathy, including eccentric exercise, 13, 16, 17 therapeutic modalities 18 (ultrasound/phonophoresis, [19] [20] [21] [22] shockwave therapy, 13 and iontophoresis 23 ), and manual therapy. 24 The variability in tendinopathic location and etiopathogenesis has made it difficult to identify efficacious treatments. Deep friction massage (DFM), popularized by James Cyriax, 24 is one of the first proposed manual treatments for tendon disorders. The beneficial effects of DFM on tendon, as proposed by Cyriax include traumatic hyperemia and increased blood flow to the tissue, elimination of adhesions, and mechanoreceptor stimulation.
An advanced understanding of the etiopathogenesis of tendinopathy and the resultant paradigm shift away from an active inflammatory model for treatment has taken place since the popularization of the DFM technique by Cyriax for the treatment of "tendinitis."
Tendinopathy, currently understood to be a maladaptation to mechanical loading, 11, 12 has been linked to a degenerative process in the absence of an inflammatory cascade. 7, 11, 13, 14 Early recognition that DFM may provide mechanical stimulus for healing 24 is intriguing. Microstructural abnormalities often found in chronic tendinopathy include abnormal alignment and degenerated extracellular matrix, inclusive and related to an increase in collagen type III production. 15 While Cyriax did not specifically define adhesions, we now know that tendinopathic tissue is disorganized and fibrous and contains increased cross-linking of collagen, as well as a preponderance of disorganized collagen III. 15 Finally, our current understanding of degenerative tendinopathy provides intuitive rationale for the beneficial effects of increasing blood flow to a degenerative tissue. Since DFM was first proposed at a time when tendon pathology was assumed to be related to an inflammatory disorder, reexamination of this treatment modality is necessary under the new paradigm of tendinopathy.
Objectives
Due to the recent paradigm shift in the etiopathogenesis of tendinopathy and the intuitive rationale for the beneficial effects of DFM, we systemically reviewed the existing literature for evidence of tendon response to DFM.
Evidence Acquisition Data Sources and Search Strategy
A comprehensive computer search was conducted in May 2011 of research related to DFM in the treatment of tendinopathy, without limits of language or year of publication. The literature search included the electronic databases PubMed, Scopus, Pedro, CINAHL, PsycINFO, and the Cochrane Library. The keywords consistently used were deep friction massage, deep tissue massage, deep transverse massage, Cyriax, soft tissue mobilization, soft tissue mobilisation, cross friction massage, and transverse friction massage. Two investigators independently screened the retrieved articles and identified potentially relevant studies by reading the abstracts. If the articles met the inclusion criteria, full articles were obtained and further reviewed. If there was disagreement as to whether an article met the inclusion criteria, the abstract was reviewed by a third author. An attempt was made to identify additional studies from the reference lists of retrieved articles.
Study Selection
Studies included in our review involved humans with a tendon injury receiving DFM as treatment. Included studies were classified and organized randomized comparison trials, nonrandomized comparison trials, and prospective noncomparison trials.
Review articles, other papers without outcome data, and nonresearch articles were excluded. Since the review is based on the effectiveness of DFM on tendon injury, articles unrelated to orthopedic DFM or focusing the treatment on muscle or ligament were excluded (Figure 1) .
Pain reduction over time and measures of functional return were the primary outcomes of interest. Pain was measured via a visual analog scale in 5 of the 9 studies. Return of function was addressed with a variety of tools such as patient report, grip strength, VAS, and a variety of functional assessment tools such as the Neer Scale and the Tennis Elbow Functional Scale.
Quality of included studies was rated using the PEDro scale. See Table 1 .
The Centre of Evidence-Based Medicine-Levels of Evidence (CEBM-LOE) was used to assess each study and to arrive at a strength of recommendation.
Evidence Synthesis
Two authors reviewed the literature search and independently determined that 30 articles should be reviewed in full text. A third-party reviewer confirmed the inclusion of each article for full-text review. Consensus was reached by all reviewers that 21 of the studies did not investigate the effectiveness of DFM on tendinous injuries, and these were then excluded.
The result of our search yielded 4 randomized comparison trials (Table 2) , 2 nonrandomized comparison trials (Table 3) , and 3 prospective noncomparison trials (Table 4) . We organized information from each article by author, experimental design, location of tendinopathy, parameters of DFM treatment, comparison-group treatment, measures, and results. Results from the CEBM-LOE grading system are shown in Table 1 .
Randomized Comparison Trials
Three randomized comparison trials [25] [26] [27] examined the effectiveness of DFM on lateral epicondylitis, and one 28 explored outlet impingement syndrome (supraspinatus tendon). The 4 randomized comparison trials compared DFM with different interventions (including low-level laser therapy, local corticosteroid injection, phonophoresis, and strengthening exercises). Although there were differences in assessment criteria, grip strength and pain were outcome measurements in all 4 studies. In comparison with a corticosteroid injection, DFM was found to be less effective in improving subjective loss of grip strength, time of return to work, resisted movement, local tenderness, localization of the point of maximal tenderness, and grip strength at 6 weeks but resulted in similar overall improvement at 1 year. 21 Vasseljen 26 found that local corticosteroid injections increased maximum grip strength in patients suffering from lateral epicondylitis more than DFM, yet the DFM group had increased results in overall strength recovery. Vasseljen concluded that corticosteroid injection in Verhaar et al 25 
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conjunction with DFM is an effective treatment for lateral epicondylitis. Nagrale et al 27 found DFM to be a significantly superior treatment to phonophoresis with exercise in improving pain-free grip strength and functional status, although both interventions diminished pain. Senbursa et al 28 determined DFM to be more effective in increasing strength and decreasing pain of the supraspinatus tendon in patients with outlet impingement syndrome than a treatment protocol consisting of strengthening exercises. Though the actual amount varied across articles, the 4 randomized comparison trials concluded DFM to be an effective treatment for treating tendinopathy.
Nonrandomized Comparison Trials
Two nonrandomized trials were included that focused on the effectiveness of DFM on lateral epicondylitis; 1 trial 29 focused on laser treatment and the effects on 
Pain, laser group:
Significant decrease in pain, from selection to end of Rx (P < .01), selection to last assessment (P < .01), and end of Rx to last assessment (P < .02). 95% CI 5.25-3.5 to 5-2.25 to 4-1.5.
Pain, traditional PT:
Significantly larger decrease in pain than laser group from selection to end of Rx, (P < .01) and selection to last assessment (P < .01). CI 6-4 to 3.5-1.5 to 2.5- 
Prospective Noncomparison Trials
Three prospective cohort studies were included with a treatment of DFM focusing on the improvement of pain and function. 31 
Summary of Results
We could not pool data on any measure assessed in this systematic review due to the heterogeneity of patient populations and involved structures, outcomes measures, and comparison treatments.
Discussion
Taken together, it appears there is evidence for the efficacy of DFM for the treatment of tendinopathy; however, several issues in comparing studies did arise centering on the lack of isolated evaluation of DFM as a treatment modality. In the 4 studies examining the effectiveness of DFM for lateral epicondylitis, 3 included a Mills manipulation immediately postmassage. In fact, Stasinopoulos and Stasinopoulos 29 attributed the benefit seen with Cyriax physiotherapy for lateral epicondylitis to the Mills manipulation. However, this question was not addressed in their study design. The single randomized comparison of DFM without a Mills manipulation and with pulsed ultrasound compared with laser treatment demonstrated a greater reduction in pain in the DFM group, as well as a better-self assessment of improvement and improvements in pain-free wrist-extension strength. 26 Assimilation of these reports makes it difficult to determine if DFM is beneficial as a stand-alone treatment for lateral epicondylitis. Studies examining treatment for supraspinatus outlet impingement have combined DFM to the supraspinatus with joint mobilization and exercise. 28, 32 One study did not have a comparison group, 32 but the randomized study conducted by Senbursa et al 28 comparing manual therapy inclusive of DFM with a home exercise program showed a superior outcome in all measures (pain, range of motion, function, and satisfaction) in the DFM group. Again, the combination of treatment modalities confounds the determination of the efficacy of DFM in isolation. The superior benefits seen with manual therapy in conjunction with strengthening of the rotator cuff as opposed to strengthening alone bring to bear an early observation that strengthening in the presence of pathologic tendon inclusive of increased intermolecular cross-links may be painful and counterproductive. 34 However, the benefits seen with eccentric training suggest that increased mechanical stimulation of the degenerative tissue may be necessary for recovery.
The notion that DFM may provide mechanical stimulation for healing is intriguing, especially given the context in which Cyriax 24 advocated this "mechanotherapy" as early as 1984. Only recently have we attained a better understanding of the mechanobiologic processes underlying tissue repair and healing. 35 While this is difficult to study in a human model, there is some poignant animal evidence that tendon massage indeed stimulates tissue adaptation at the cellular level.
Davidson et al 36 and Gehlsen et al, 37 using a collagenase-induced tendinopathy model on rat Achilles tendons, examined the effect of soft-tissue mobilization on cell and extracellular matrix response. Davidson et al 36 compared 4 groups: control, induced tendinitis, tendinitis plus soft-tissue massage (STM), and STM alone. Groups receiving STM had more fibroblasts present. The STM groups also stained positive for increased fibronectin, an extracellular matrix adhesion protein. Both hypercellularity and up-regulation of fibronectin production occur in the early healing response. 38 In addition, electron microscopy demonstrated highly developed rough endoplasmic reticulum in the fibroblasts of the tendinopathic group receiving STM, indicative of stimulated extracellular matrix production. Using the same model of experimentation, Gehlsen et al 37 examined the effect of altered levels of pressure during STM and found that the heaviest pressure resulted in the largest number of fibroblasts after 6 sessions of STM on rat Achilles tendons.
While discussion of animal-model tissue research in the midst of an article examining the effectiveness of DFM on human tendinopathy may seem out of context, the recent paradigm shift of understanding tendon disease has occurred at the tissue level. We therefore feel that a discussion of tissue response to the mechanical stimulation of the tendon cell and surrounding extracellular matrix is crucial. We also point out that the very early observation by Cyriax that mechanical signal to the cell is vital to tissue healing was quite farsighted. Other proposed benefits of DFM-increasing blood flow to promote an inflammatory response and decreasing pathologic intermolecular crosslinking-are also consistent with our recent understanding of the histopathology of tendinopathy.
Conclusion
The analysis of articles revealed evidence for the incorporation of DFM in the treatment of tendinopathy.
Comparison of studies was made difficult by the varied location of tendinopathies, confounding cotreatments in comparison groups, and varied outcome measures used. Much of the original rationale for the use of DFM remains valid in light of a complete shift in understanding of the pathogenesis of tendinopathy. Future randomized comparison studies are necessary that incorporate true control groups and compare DFM in isolation with other modes of treatment. Studies such as these are very difficult to undertake, as they inherently deny treatment to a group of participants.
